Zowin

Name

Zowin

Legal name

(주)조윈|JOWIN Healthcare Platform

Website

https://jowin.info

Company type

Private

Founded year

2015

Operating status

Operating

Ownership category

akta.pro rank

Product category

Preventive Healthcare Services

NAICS

Home Health Care Services (62161), Food (Health) Supplement Retailers (456191)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Health Services (8000)

akta.pro industry

PRIMARYHLALADAK

Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine)

Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms

SECONDARYHLAHACAI

Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYCRADAGAE

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYHSADAGAH

Chronic Condition Lifestyle Coaching (Non-Clinical)

Home & Personal Services/Fitness, Wellness & Personal Training/Health Coaching & Lifestyle Wellness

Keywords

• Integrated healthcare platform
• Preventive nutrition solutions
• Insurance-linked wellness
• Cancer therapy devices
• Immune enhancement supplements

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Health Subscription Products: Regular subscription model for preventive nutritional supplements, health devices, and functional health products. Customers subscribe monthly to nutritional supplements and health devices, generating recurring revenue. The subscription automatically links to insurance coverage.
2. MIT Therapy Products & Services: Revenue from proprietary Micacine (운비제) mineral-based therapeutic products and DR. K-CURE high-frequency hyperthermia devices. Products include both professional institutional models and personal home care models with home rental options.
3. Health-Insu License Fees: Licensing revenue from the Health-Insu certification system. Partner companies selling verified health products through the Health-Insu platform pay licensing fees. Companies can apply for Health-Insu license through the official application process.
4. Insurance Partnership Revenue: Revenue from partnerships with insurance companies including Hyundai Marine & Fire Insurance (현대해상) and 5 other domestic and overseas insurers for co-development of Health-Insu linked insurance products.
5. Partnered Health Product Sales: Revenue from sales of certified partner products including Dr's PGA Immunity Up, Jinsenginsoo (진생인수), and Exoden through the Health-Insu platform.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

JOWIN operates an integrated preventive healthcare platform that combines certified nutritional supplements, hyperthermia medical devices, digital health applications, and insurance-linked subscription services under the Health-Insu (헬스인슈) brand. Its therapeutic business is anchored by the MIT Therapy program, which pairs the proprietary Micacine (운비제) mineral-based supplement with the DR. K-CURE 43°C high-frequency hyperthermia device for cancer and chronic disease care. The platform is sold both to individual consumers via monthly subscriptions and to partner companies, hospitals, and insurers via licensing and distribution agreements.

Product overview

JOWIN operates as an integrated healthcare ecosystem spanning prevention through treatment and recovery, built around three core business areas: Health-Insu™ platform (preventive nutrition subscription with insurance integration), MIT Therapy (cancer and chronic disease care combining Micacine mineral therapeutics and DR. K-CURE hyperthermia), and Lifetime Healthcare Solutions (data-driven anti-aging and precision medicine). The Health-Insu™ platform serves as the core subscription model, connecting preventive nutritional supplements and health devices with insurance protection, verified through insurance loss ratio data and hospital clinical screening data. MIT Therapy integrates proprietary products (Micacine/Unbije, DR. K-CURE) with cancer management programs. The ecosystem extends through HI-Clinic hospital partnership networks, partnered Health-Insu certified products (Dr's PGA Immunity Up, Jinsenginsoo, Exoden), and social contribution initiatives including KQ-ART healing art and MIT Therapy donation programs. The company also offers Cancerport, a psychological counseling app for cancer patients.

Differentiator

Problem solved

Functional benefit

Brands

• Health-Insu™: 보험 연계형 건강관리 플랫폼 - 예방 영양제, 정기검진, 맞춤형 보험보장이 결합된 통합 헬스케어 서비스
• MIT Therapy™
• 운비제(Micacine)
• DR. K-CURE
• 캔서포트(CancerPort)
• KQ-ART

Products and services

• Health-Insu (헬스인슈) Integrated Care Platform Subscription-based integrated preventive care platform that links certified nutritional supplements, home health devices, clinical screening, and insurance coverage into a single member offering for South Korean consumers.
• Micacine (운비제) Proprietary mineral-based nutritional therapeutic, formulated from the company's controlled sericite supply, used to support immune function and as the supplement component of the MIT Therapy cancer and chronic-disease protocol.
• DR. K-CURE High-Frequency Hyperthermia System 43°C high-frequency hyperthermia medical device used in MIT Therapy for cancer and chronic-disease care, deployed in the HI-Clinic hospital network and through international hospital partners.
• MIT Therapy Program Integrated adjuvant cancer and chronic-disease care program that combines the Micacine mineral supplement with the DR. K-CURE 43°C high-frequency hyperthermia device, offered to individual patients and through clinical partners.
• Cancerport Psychological Counseling Application Mobile/web application delivering psychological counseling and emotional support services for cancer patients and their families, integrated with JOWIN's broader MIT Therapy care offering.
• Cansalgi (캔살기) Personal Hyperthermia Device Personal-use hyperthermia device introduced for home rental by cancer and chronic-disease patients as a consumer/home counterpart to the clinical DR. K-CURE system.
• Lifetime Healthcare Solution Genomic and preventive-health testing program that maps individual disease risk profiles (including cancer, dementia, and other conditions) and feeds personalized supplement and lifestyle recommendations through the Health-Insu platform.

Quantifiable outcome

• NK and T-cell activation-based immune enhancement clinically demonstrated at 52.3% immune activation rate
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

Partnerships

16 partnerships are on record, tiered core, minor and flagship.

• Buk Seoul Geriatric Hospital (북서울요양병원)coreTechnology or Integration · 1 June 2025Clinical observation partnership for treating terminal and advanced cancer patients. Agreement for MITT Cancer Solution observation clinical trial signed June 2025 with Buk Seoul Geriatric Hospital.
• Gogorealbox (고고리얼박스)minorGTM or Marketing Partner · 1 April 2025Joint operation of a cancer patient referral product shopping platform. Gogorealbox partnered with JOWIN to jointly operate a shopping platform recommending products for cancer patients.
• Sanggye Gangwon Medical Institution - 상경원인터메드요양병원coreTechnology or Integration · 30 December 2024Observation clinical partnership for terminal stage 4 cancer patients. SKJ Sanggye-intermediate and JOWIN collaborated on ORT Therapy observation clinical trial for cancer patients. Announced December 2024.
• IMPRIMED (임프리메드)coreStrategic or Co-development Partner · 1 July 2024Joint research and development partnership for AI precision medical-based optimal anticancer adjuvant development. Combines JOWIN's cancer care expertise with IMPRIMED's AI precision medicine technology.
• MindCafe (마인드카페)coreTechnology or Integration · 14 March 2024Partnership for developing cancer patient counseling service platform. Aimed at creating a mental health support platform for cancer patients, combining MindCafe's counseling expertise with JOWIN's cancer care ecosystem.
• Hi-Zen Care (하이젠케어)flagshipChannel Partner/ Reseller/ DistributorHi-Zen Care serves as the master distribution partner for the entire Health-Insu platform, managing overall product circulation and partner relationship management. Website: hijowin.co.kr.
• Ham Partners Group (함파트너스그룹)coreGTM or Marketing PartnerAdvertising and marketing partnership for brand and campaign planning and integrated promotional operations. Manages brand campaigns and promotional activities for the Health-Insu ecosystem.
• Moalifeplus (모아라이프플러스)coreTechnology or IntegrationHealth product supply partner providing preventive nutritional supplements and Health-Insu products. Also serves as distribution channel for partnered products including Dr's PGA Immunity Up.
• Koryuwon (고려원)coreTechnology or IntegrationHealth product supply partner specializing in Korean traditional herbal formulations. Provider of Jinsenginsoo (진생인수) product with proprietary MSM and Korean ginseng saponin (ginsenoside) complex formula.
• Lifeonbio (라이프온)coreTechnology or IntegrationHealth product supply partner contributing to the Health-Insu product portfolio and preventive nutritional supplement ecosystem.
• Mediage (메디에이지)coreTechnology or IntegrationHealth data partnership for bio data-based health indicator analysis and clinical collaboration. Provides health data analytics capabilities for the Health-Insu data verification system.
• Hyundai Marine & Fire Insurance (현대해상) and 5 additional insurance companiesflagshipStrategic or Co-development PartnerInsurance partnership for co-development of Health-Insu linked insurance products. Insurance companies provide loss ratio data for product efficacy verification and receive access to Health-Insu subscription model for risk management. Partnership with Hyundai Marine & Fire Insurance (hi.co.kr) plus 5 additional domestic and overseas insurers.
• ATAKA Co. LTDminorOEM/ Whitelabel/ Licensing PartnerAnticancer product licensing agreement with Japanese company ATAKA Co. LTD. Involves licensing of JOWIN's anticancer product technology or formulations.
• Wellness Medi (Philippines)coreChannel Partner/ Reseller/ DistributorExclusive global distribution partnership for the Philippine market. Brings JOWIN's Health-Insu ecosystem and products to Southeast Asian markets through exclusive licensing arrangement.
• HL GROUP (Bangladesh)minorChannel Partner/ Reseller/ DistributorPartnership with Bangladesh-based HL GROUP for global market entry. Represents JOWIN's expansion into South Asian markets through local partner representation.
• Noble HospitalsminorChannel Partner/ Reseller/ DistributorCooperation agreement with Noble Hospitals for medical collaboration. Part of the HI-Clinic network expansion and international hospital partnership strategy.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Oscar Health: US health insurer building a tech-led platform that integrates insurance with care navigation and preventive health data. Closest comparable to JOWIN's insurance-embedded preventive healthcare concept, though operating in a different regulatory and reimbursement environment.
• Ritual: US subscription-based supplements company with traceable, clinically validated ingredients. Comparable to JOWIN's data-verified nutrition subscription model and target segment of health-conscious preventive care consumers.
• Bukwang Pharmaceutical: Korean pharmaceutical company with prescription drugs, OTC products, and consumer health supplements including CNS and metabolic therapy areas. Comparable to JOWIN in the Korean health functional food and integrative care space.

Broad incumbents

• Celltrion: Major Korean biopharmaceutical company with biosimilars, biologics, and growing consumer health portfolio. A broad incumbent in the Korean healthcare market and a potential partner/acquirer for JOWIN's oncology and supplement businesses.
• Genexine: Korean clinical-stage biotech developing immunotherapies and DNA vaccines, including oncology candidates. Comparable to JOWIN's cancer immunotherapy positioning and Korean biotech R&D pipeline.
• Kwang Dong Pharmaceutical: Korean pharmaceutical and health functional food manufacturer with broad consumer health and OTC presence. Comparable to JOWIN's supplement and functional health products distributed via pharmacy and consumer channels in Korea.
• Hims & Hers Health: US direct-to-consumer telehealth and wellness subscription platform combining personalized supplements, prescription products, and health services. Comparable to JOWIN's subscription-based Health-Insu D2C model for preventive health and nutrition.

Direct peers

• Pyrexar Medical: US-based manufacturer of hyperthermia/cancer treatment devices using radiofrequency and microwave technology to heat deep tissue. Directly comparable to JOWIN's DR. K-CURE high-frequency hyperthermia system targeting the same oncology adjunctive therapy use case.
• Yuyu Pharma: Korean pharmaceutical company with consumer health supplements, OTC products, and medical device portfolio. Most direct Korean peer in the supplement/functional health product distribution and hospital channel business.
• Oncotherm: German-Hungarian developer of capacitive hyperthermia devices (EHY-2000, EHY-2030) for cancer treatment. Most direct global competitor to JOWIN's DR. K-CURE in the localized deep-tissue hyperthermia category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/jowin.co.kr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zowin